217 related articles for article (PubMed ID: 11753654)
1. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
4. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.
Li AG; Lu SL; Zhang MX; Deng C; Wang XJ
Cancer Res; 2004 Nov; 64(21):7836-45. PubMed ID: 15520189
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.
Schwalbe M; Sänger J; Eggers R; Naumann A; Schmidt A; Höffken K; Clement JH
Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
7. AP-1 expression in ethanol-treated corneal epithelium in vivo.
Okada Y; Saika S; Miyamoto T; Shirai K; Ueyama T; Senba E; Ohnishi Y
Ophthalmic Res; 2007; 39(2):84-91. PubMed ID: 17284934
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
10. Induction of PDGF-B in TCA-treated epidermal keratinocytes.
Yonei N; Kanazawa N; Ohtani T; Furukawa F; Yamamoto Y
Arch Dermatol Res; 2007 Nov; 299(9):433-40. PubMed ID: 17724602
[TBL] [Abstract][Full Text] [Related]
11. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
[TBL] [Abstract][Full Text] [Related]
12. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
Rodríguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ
Oncogene; 1998 Feb; 16(7):853-63. PubMed ID: 9484776
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4.
Kim SG; Chae CH; Cho BO; Kim HN; Kim HJ; Kim IS; Choi JY
J Oral Pathol Med; 2006 Jan; 35(1):37-45. PubMed ID: 16393252
[TBL] [Abstract][Full Text] [Related]
14. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
15. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice.
Kaiser S; Schirmacher P; Philipp A; Protschka M; Moll I; Nicol K; Blessing M
J Invest Dermatol; 1998 Dec; 111(6):1145-52. PubMed ID: 9856831
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
17. Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin.
Fowlis DJ; Flanders KC; Duffie E; Balmain A; Akhurst RJ
Cell Growth Differ; 1992 Feb; 3(2):81-91. PubMed ID: 1504019
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
19. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
20. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
